Trial reportJournal of nuclear medicine : official publication, Society of Nuclear Medicine2016
Repeatability of Quantitative 18F-NaF PET: A Multicenter Study.
Trial report in Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
41 citing papers in PubMed, 69 citations in OpenAlex.
- Quantitative Analysis of Serial Positron Emission Tomography Imaging in Men with Metastatic Castration-resistant Prostate Cancer Treated with Enzalutamide.European urology oncology · 2024Trial
- Phase 2 trial of a DNA vaccine (pTVG-HP) and nivolumab in patients with castration-sensitive non-metastatic (M0) prostate cancer.Journal for immunotherapy of cancer · 2023Trial
- Whole-Body [Tomography (Ann Arbor, Mich.) · 2021Trial
- Cabozantinib in patients with platinum-refractory metastatic urothelial carcinoma: an open-label, single-centre, phase 2 trial.The Lancet. Oncology · 2020Trial
- Phase II Trial of a DNA Vaccine Encoding Prostatic Acid Phosphatase (pTVG-HP [MVI-816]) in Patients With Progressive, Nonmetastatic, Castration-Sensitive Prostate Cancer.Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2019Trial
- Prediction of therapy response in bone-predominant metastatic breast cancer: comparison of [European journal of nuclear medicine and molecular imaging · 2019Trial
- Reproducibility and Repeatability of SemiquantitativeJournal of nuclear medicine : official publication, Society of Nuclear Medicine · 2018Trial
- Quantitative Assessment of Early [Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2017Trial
- Molecular image-directed biopsies: improving clinical biopsy selection in patients with multiple tumors.Physics in medicine and biology · 2016Trial
- Repeatability of Semi-Quantitative and Volumetric Features from Artificial-Intelligence-Guided Lesion Segmentation onTomography (Ann Arbor, Mich.) · 2026Article
- Can radiomics signatures and machine learning methods reinforce the revived role ofAsia Oceania journal of nuclear medicine & biology · 2026Article
- Advanced Image Analysis to Select Patients for Prostate Specific Membrane Antigen Radioligand Therapy and Assess Treatment Response.Advances in radiation oncology · 2025Article
- Full-Body Tumor Response Heterogeneity of Metastatic Neuroendocrine Tumor Patients Undergoing Peptide Receptor Radiopharmaceutical Therapy.Journal of nuclear medicine : official publication, Society of Nuclear Medicine · 2025Article
- Uncertainty quantification via localized gradients for deep learning-based medical image assessments.Physics in medicine and biology · 2024Article
- Article
- The value of baseline 18F-sodium fluoride and 18F-choline PET activity for identifying responders to radium-223 treatment in castration-resistant prostate cancer bone metastases.European radiology · 2024Article
- [Frontiers in nuclear medicine · 2023Article
- A systematic evaluation of five different image-derived input functions for the clinical implementation ofFrontiers in nuclear medicine · 2023Article
- EARL compliance measurements on the biograph vision Quadra PET/CT system with a long axial field of view.EJNMMI physics · 2022Article
- Cabozantinib plus Nivolumab Phase I Expansion Study in Patients with Metastatic Urothelial Carcinoma Refractory to Immune Checkpoint Inhibitor Therapy.Clinical cancer research : an official journal of the American Association for Cancer Research · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors at 6 institutions in 1 country.
Funding
Abstract
methodsThirty-five castration-resistant prostate cancer patients with multiple metastases underwent 2 whole-body (test-retest)
resultsAt the lesion level, the coefficient of variation for SUV
conclusionThe repeatability of SUV
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.